Journal ArticleOPEN ACCESS

Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019

  • Bhatnagar V
  • Hudgens S
  • Piault-Louis E
  • et al.
The Oncologist (2020) 25(10) 819-821
DOI: 10.1634/theoncologist.2020-0062
8Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The measurement and analysis of patient-reported outcomes is important in cancer clinical trials. This commentary reports advances and challenges from presentations at the 2019 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop Patient-Reported Outcomes Session.

Cite

CITATION STYLE

APA

Bhatnagar, V., Hudgens, S., Piault-Louis, E., Jones, L., Beaver, J. A., Lyerly, H. K., … Kluetz, P. G. (2020). Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019. The Oncologist, 25(10), 819–821. https://doi.org/10.1634/theoncologist.2020-0062

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free